Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inhibitor of apoptosis proteins (IAPs) are a family of proteins that inhibit apoptosis by blocking caspase activation or activity. They also regulate immune signaling and inflammation through their E3 ubiquitin ligase activity. IAPs are therapeutic targets in cancer due to their overexpression in many tumors.
Smac mimetics restore sensitivity to apoptosis in tumor cells by neutralizing the anti-apoptotic effects of IAPs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inhibitor of Apoptosis Protein (IAP).